These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 33181025)
1. Engeletin ameliorates pulmonary fibrosis through endoplasmic reticulum stress depending on lnc949-mediated TGF-β1-Smad2/3 and JNK signalling pathways. Zhang J; Chen X; Chen H; Li R; Xu P; Lv C; Liu B; Song X Pharm Biol; 2020 Dec; 58(1):1105-1114. PubMed ID: 33181025 [TBL] [Abstract][Full Text] [Related]
2. Acetyl oxygen benzoate engeletin ester promotes KLF4 degradation leading to the attenuation of pulmonary fibrosis via inhibiting TGFβ1-smad/p38MAPK-lnc865/lnc556-miR-29b-2-5p-STAT3 signal pathway. Shen K; Li R; Zhang X; Qu G; Li R; Wang Y; Liu B; Lv C; Li M; Song X Aging (Albany NY); 2021 Apr; 13(10):13807-13821. PubMed ID: 33929970 [TBL] [Abstract][Full Text] [Related]
3. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway. Li S; Xu A; Li Y; Tan C; La Regina G; Silvestri R; Wang H; Qi W Eur J Pharmacol; 2021 Jul; 903():174135. PubMed ID: 33940030 [TBL] [Abstract][Full Text] [Related]
4. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo. Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129 [TBL] [Abstract][Full Text] [Related]
5. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163 [TBL] [Abstract][Full Text] [Related]
6. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway. Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758 [TBL] [Abstract][Full Text] [Related]
7. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice. Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239 [TBL] [Abstract][Full Text] [Related]
8. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376 [TBL] [Abstract][Full Text] [Related]
9. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition. Lu GX; Bian DF; Ji Y; Guo JM; Wei ZF; Jiang SD; Xia YF; Dai Y Phytother Res; 2014 Aug; 28(8):1224-31. PubMed ID: 24458872 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation. Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001 [TBL] [Abstract][Full Text] [Related]
11. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling. Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535 [TBL] [Abstract][Full Text] [Related]
12. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition. Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658 [TBL] [Abstract][Full Text] [Related]
13. Geniposide ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β/Smad and p38MAPK signaling pathways. Yin JB; Wang YX; Fan SS; Shang WB; Zhu YS; Peng XR; Zou C; Zhang X PLoS One; 2024; 19(9):e0309833. PubMed ID: 39240867 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop. Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219 [TBL] [Abstract][Full Text] [Related]
15. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation. Kim S; Lim JH; Woo CH Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924 [TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302 [TBL] [Abstract][Full Text] [Related]
18. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation. Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992 [TBL] [Abstract][Full Text] [Related]
19. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis. Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194 [TBL] [Abstract][Full Text] [Related]
20. Amelioration of bleomycin-induced pulmonary fibrosis by chlorogenic acid through endoplasmic reticulum stress inhibition. Wang YC; Dong J; Nie J; Zhu JX; Wang H; Chen Q; Chen JY; Xia JM; Shuai W Apoptosis; 2017 Sep; 22(9):1147-1156. PubMed ID: 28677092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]